What Are the Challenges in Targeting the Mitotic Process?
The primary challenge in targeting mitosis for cancer treatment is the potential for toxicity in normal dividing cells, leading to side effects. Additionally, cancer cells can develop resistance to mitotic inhibitors, often by upregulating alternative pathways or acquiring mutations in drug targets. Research is ongoing to develop more selective targeted therapies and to identify biomarkers for predicting treatment response.
